Brilinta 60mg Tablet
Marketer
AstraZeneca
Salt Composition
Ticagrelor (60mg)
Overview Brilinta 60mg Tablet
Ticagrelor 60mg tablets are antiplatelet agents, also known as blood thinners. They inhibit the formation of dangerous blood clots within blood vessels, thus lowering the risk of heart attack or stroke in patients with cardiac conditions. This medication is also indicated for individuals who have recently experienced a heart attack or acute coronary syndrome (unstable angina) and have received a coronary stent. It helps prevent further cardiac events such as recurrent heart attack, stroke, or stent thrombosis. Concurrently, your physician will likely prescribe aspirin, another antiplatelet drug. Ticagrelor 60mg tablets can be administered with or without food, consistently at the same time daily. Continuous use is crucial, even during symptom-free periods, as discontinuation may increase the risk of future cardiovascular events. The most prevalent adverse effect is bleeding, potentially prolonging bleeding time from injuries. While usually minor and self-limiting, persistent or excessive bleeding should be reported. Some individuals may experience mild dyspnea, typically resolving spontaneously. However, worsening or persistent shortness of breath requires medical attention. This medication is contraindicated in patients with active bleeding, such as gastric ulcers or intracranial hemorrhage, and is not recommended for those with hepatic impairment. Always disclose any relevant medical history to your doctor prior to commencing treatment.
Uses of Brilinta 60mg Tablet
Cardiovascular event prophylaxis
Major Benefits of Brilinta 60mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 60mg Brilinta tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Brilinta 60mg Tablet:
- Bleeding
- Breathlessness
How to use Brilinta 60mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 60mg Brilinta tablet whole; do not alter its form by chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistency is key—take it at the same time each day.
How Brilinta 60mg Tablet works:
Ticagrelor 60mg tablets are antiplatelet agents that inhibit platelet aggregation, reducing the risk of dangerous thrombus formation and consequently lowering the likelihood of myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while taking Brilinta 60mg tablets. Seek your physician's advice.
PregnancyCONSULT YOUR DOCTOR
Use of Brilinta 60mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Brilinta 60mg tablets with breastfeeding are lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Brilinta 60mg tablets.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Ticagrelor 60mg tablets are considered safe, and no dosage modification is advised. Data regarding the use of Ticagrelor 60mg tablets in patients undergoing renal dialysis is currently limited.
LiverCAUTION
Ticagrelor 60mg tablets require careful administration in individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Ticagrelor 60mg tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Brilinta 60mg Tablet :
Should you forget a Brilinta 60mg Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Brilinta 60mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | ADP receptor antagonists (P2Y12 inhibitors) |



